Candidate Screening & Feasibility Studies For Emerging Biotechs Developing Viral Gene Therapies

To meet the demands of the early phase market, flexible viral vector Drug Candidate Screening and Feasibility Studies can help companies and research institutions quickly overcome preclinical and Phase I hurdles such as budget and timeframe constraints. The aim of the early phase assessment studies is to create a simple, modular path to cGMP manufacturing that minimizes risk and streamlines drug substance and drug product manufacture for the clinic.

This presentation focuses on this strategic, effective approach for early stage development and how it can propel therapies to the clinic and the market.


  • What Candidate Screenings and Feasibility Studies involve
  • What a modular approach looks like and what its benefits are
  • How this can facilitate a faster path to cGMP
access the Webinar!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Outsourced Pharma

FUJIFILM Diosynth Biotechnologies